
    
      The secondary goals of this study are to:

        -  determine the safety of bilateral injections of Myobloc into the parotid and
           submandibular glands as an effort to control sialorrhea;

        -  determine by objective measures if the Myobloc injection decreases the saliva produced;

        -  determine caregiver perceived benefit from Myobloc injection.
    
  